Skip to main content
The Joint Corp. (JYNT)
NASDAQ: JYNT · IEX Real-Time Price · USD
15.01
-0.08 (-0.53%)
May 31, 2024, 4:00 PM EDT - Market closed

The Joint Revenue

The Joint had revenue of $119.12M in the twelve months ending March 31, 2024, with 11.00% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $29.72M with 5.02% year-over-year growth. In the year 2023, The Joint had annual revenue of $117.70M with 16.24% growth.

Revenue (ttm)
$119.12M
Revenue Growth
+11.00%
P/S Ratio
1.89
Revenue / Employee
$268,283
Employees
444
Market Cap
224.76M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023117.70M16.44M16.24%
Dec 31, 2022101.25M21.24M26.55%
Dec 31, 202180.01M21.33M36.34%
Dec 31, 202058.68M10.23M21.12%
Dec 31, 201948.45M11.79M32.16%
Dec 31, 201836.66M11.74M47.12%
Dec 31, 201724.92M4.40M21.42%
Dec 31, 201620.52M6.69M48.34%
Dec 31, 201513.84M6.72M94.41%
Dec 31, 20147.12M1.16M19.45%
Dec 31, 20135.96M3.17M113.94%
Dec 31, 20122.78M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Akebia Therapeutics 187.23M
Nektar Therapeutics 90.17M
2seventy bio 71.20M
Innate Pharma 68.49M
Senseonics Holdings 23.30M
uniQure 19.00M
Revenue Rankings

JYNT News

More News